XML 70 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies - Narrative (Details)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Nov. 27, 2022
USD ($)
segment
$ / shares
shares
Nov. 27, 2022
USD ($)
$ / shares
shares
Nov. 28, 2021
USD ($)
$ / shares
shares
Nov. 29, 2020
USD ($)
$ / shares
May 29, 2022
USD ($)
Nov. 24, 2019
USD ($)
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Number of reportable segments | segment 3          
Charges Incurred by COVID       $ 250.0    
Restructuring charges   $ 9.1 $ 8.3 90.4    
COVID-19 related inventory costs       68.5    
Other Restructuring Costs       91.1    
Other income (expense), net   28.8 3.4 (22.4)    
Income tax expense (benefit)   $ 80.5 $ 26.7 $ (62.6)    
Earnings per share, basic (in usd per share) | $ / shares   $ 1.43 $ 1.38 $ (0.32)    
Earnings per share, diluted (in usd per share) | $ / shares   $ 1.41 $ 1.35 $ (0.32)    
Payments to acquire business   $ 0.0 $ 390.9 $ 54.6    
Goodwill acquired     125.4      
Selling, general and administrative expenses   2,893.2 2,652.2 2,347.6    
Net income   569.1 553.5 (127.1)    
Share-based compensation expense   63.6 64.9 51.3    
Advertising expense   463.7 434.5 331.4    
Operating lease liabilities $ 1,094.8 1,094.8        
Operating lease right-of-use assets, net 970.0 970.0 $ 1,103.7      
COVID related accounts receivable charges reversal       5.2    
Reduction to inventory valuation       42.3    
Share repurchase program, authorized amount 750.0 $ 750.0     $ 200.0  
Shares repurchased (in shares) | shares   8,700,000 3,400,000      
Repurchased value   $ 172.9 $ 88.4      
Distribution costs   304.7 244.6 198.3    
Cumulative effect of adoption of new accounting standards 1,903.7 1,903.7 1,665.7 1,299.5   $ 1,571.6
Accounts Receivable, Allowance for Credit Loss, Current $ 7.5 7.5 11.6      
Revision In Current Period, Adjustment            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Other income (expense), net   19.9        
Income tax expense (benefit)   $ 4.0        
Earnings per share, basic (in usd per share) | $ / shares   $ 0.04        
Earnings per share, diluted (in usd per share) | $ / shares   $ 0.04        
COVID-19            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
COVID related accounts receivable charges reversal     (12.5)      
Cumulative Effect, Period of Adoption, Adjustment            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Cumulative effect of adoption of new accounting standards           5.4
2019 Equity Incentive Plan            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Number of shares authorized (shares) | shares 40,000,000 40,000,000        
Additional Paid-In Capital            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Cumulative effect of adoption of new accounting standards $ 625.6 $ 625.6 584.8 626.2   657.7
Accumulated Other Comprehensive Loss            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Cumulative effect of adoption of new accounting standards $ (421.7) $ (421.7) $ (394.4) $ (441.4)   (405.0)
Accumulated Other Comprehensive Loss | Cumulative Effect, Period of Adoption, Adjustment            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Cumulative effect of adoption of new accounting standards           $ (54.4)
Common Class A            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Common stock, par value (usd per share) | $ / shares $ 0.001 $ 0.001 $ 0.001      
Common stock, shares authorized (shares) | shares 1,200,000,000 1,200,000,000 1,200,000,000      
Common Class B            
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Common stock, shares authorized (shares) | shares 422,000,000 422,000,000 422,000,000